Respiratory

Explore a range of educational and practical resources tailored to support clinical practice in respiratory disease management.

Chronic obstructive pulmonary disease (COPD)

Two people seated facing each other in chairs, engaged in conversation.

Overview of COPD

The burden of COPD and its impact on patients' lives.

Learn more
A healthcare professional sitting on a stool speaking with a parent holding a child in a medical examination room.

Burden of exacerbations

Managing exacerbations and the patient burden of COPD.

Learn more
A healthcare professional reviews information on a tablet with a standing patient during a consultation.

Personalised care

The role of treatable traits and management strategies in delivering personalised COPD care.

Learn more
Two scientists in lab coats work together at a lab bench, examining samples and recording results.

Type 2 inflammation

The pathophysiological processes and cellular impact of type 2 inflammation in COPD.

Learn more
A person at a reception desk greets and speaks with an older adult seated nearby in a clinic waiting area.

Community care

Integrated care for patient self-management in
community settings.

Coming soon

Severe asthma

Two people exercise in a gym, one lifting weights on a machine while another performs a lunge nearby.

Challenges and goals

Challenges in the treatment of severe asthma and goals for management of care.

Learn more
Two clinicians engaging in conversation in a medical office.

Clinical management and primary care

Severe asthma in clinical practice and corticosteroid use in primary care.

Learn more
Two scientists in lab coats work together at a lab bench, examining samples and recording results.

IL-5 and type 2 inflammation

The pathophysiological processes and cellular impact of type 2 inflammation and IL-5 in severe asthma.

Learn more

Featured resources

NA

Our Mission in Respiratory care

This policy document highlights the burden of respiratory disease (asthma and COPD) in the UK and underscores the need to prioritise respiratory care. It identifies opportunities to improve care through earlier diagnosis, ensuring access to high-quality treatment, improving access to innovative medicines and reducing the carbon footprint of respiratory care. The report recommends a targeted policy agenda, investment in diagnostic services, consistent implementation of clinical guidelines, and innovative approaches to medicine access to address disparities and improve patient outcomes.

NP-GB-RS-COCO-250005 I February 2026

View now
NA

Redefining Respiratory Care

GSK's "Redefining Respiratory Care" outlines the company's commitment to innovation in respiratory medicine, with the aim of preventing, treating, and stopping disease progression. The report highlights GSK's long-standing investment in research and development, collaborations with the NHS, and initiatives like the Cambridge-GSK Translational Immunology Collaboration, all focused on improving patient outcomes and access to care in respiratory health.

NP-GB-RS-COCO-250004 I February 2026

Coming Soon
Dr Hitasha Rupani presenting slide deck

Narrated scientific presentation: The role of IL-5 in severe asthma | Intended for
treating clinicians

Watch Dr Hitasha Rupani, Consultant Respiratory Physician at University Hospital Southampton, discuss the role of IL-5 in type 2 inflammation, highlighting the interconnected mechanisms driving airway inflammation and the resulting clinical signs and disease burden.

NX-GB-ASU-VID-250002 I January 2026

View now
Diagram detailing the role of IL-5 in type 2 inflammation

Infographic:
The role of IL-5 in severe asthma | Intended for
treating clinicians

This infographic tells the visual story of the interconnected roles of IL-5 and type 2 inflammation in the underlying processes and clinical manifestations of severe asthma.

NX-GB-ASU-LBND-250001 I December 2025

View now

Abbreviations

COPD, chronic obstructive pulmonary disease; IL, interleukin.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com

June 2026 | NP-GB-ASU-WCNT-250001 (V5.0)